GPT and metabolic dysfunction-associated steatotic liver disease: Demir et al. observed that NAFLD rather than CHB may be the most common cause of elevated alanine transaminase (ALT) levels among patients with HBeAg-negative CHB and HBV DNA levels < 2000 IU/mL [46].